Literature DB >> 17332672

Up-regulation of vascular cyclooxygenase-2 in diabetes mellitus.

Zsolt Bagi1, Nóra Erdei, Zoltán Papp, István Edes, Akos Koller.   

Abstract

Diabetes mellitus is associated with disturbed regulation in the microcirculation. A low-grade vascular inflammation has been implicated in the development of diabetes-related vascular complications, but the underlying molecular mechanisms has not yet been fully elucidated. It is known that cyclooxygenase-2 (COX-2) plays a key role in prostaglandin biosynthesis during the development of inflammation. Recent studies revealed that in diabetes increased synthesis of various prostanoids, via up-regulation of COX-2, interferes with the regulation of vasomotor function. In this review, we will summarize the current findings regarding the role of COX-2, and COX-2-derived prostanoids in the regulation of vascular tone, as well as the possible underlying mechanisms leading to COX-2 activation in diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17332672

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  15 in total

Review 1.  Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes.

Authors:  Takayuki Matsumoto; Styliani Goulopoulou; Kumiko Taguchi; Rita C Tostes; Tsuneo Kobayashi
Journal:  Br J Pharmacol       Date:  2015-07-08       Impact factor: 8.739

2.  Angiotensin-(1-7) via the mas receptor alleviates the diabetes-induced decrease in GFAP and GAP-43 immunoreactivity with concomitant reduction in the COX-2 in hippocampal formation: an immunohistochemical study.

Authors:  Waleed M Renno; Anwar G Al-Banaw; Preethi George; Asmaa A Abu-Ghefreh; Saghir Akhtar; Ibrahim F Benter
Journal:  Cell Mol Neurobiol       Date:  2012-06-19       Impact factor: 5.046

Review 3.  Coronary microvascular dysfunction in diabetes mellitus.

Authors:  Aleksandar Kibel; Kristina Selthofer-Relatic; Ines Drenjancevic; Tatjana Bacun; Ivica Bosnjak; Dijana Kibel; Mario Gros
Journal:  J Int Med Res       Date:  2017-01-12       Impact factor: 1.671

4.  Nicotine augments glomerular injury in a rat model of acute nephritis.

Authors:  Edgar A Jaimes; Run-Xia Tian; Mahesh S Joshi; Leopoldo Raij
Journal:  Am J Nephrol       Date:  2008-10-10       Impact factor: 3.754

5.  Endothelial dysfunction in mice with streptozotocin-induced type 1 diabetes is opposed by compensatory overexpression of cyclooxygenase-2 in the vasculature.

Authors:  Carmela Nacci; Mariela Tarquinio; Leonarda De Benedictis; Annamaria Mauro; Addolorata Zigrino; Maria Rosaria Carratù; Michael J Quon; Monica Montagnani
Journal:  Endocrinology       Date:  2008-10-09       Impact factor: 4.736

Review 6.  Nicotine signaling and progression of chronic kidney disease in smokers.

Authors:  Gaurav Jain; Edgar A Jaimes
Journal:  Biochem Pharmacol       Date:  2013-07-26       Impact factor: 5.858

7.  Etoricoxib treatment prevented body weight gain and ameliorated oxidative stress in the liver of high-fat diet-fed rats.

Authors:  Fariha Kabir; Kamrun Nahar; Md Mizanur Rahman; Fariha Mamun; Shoumen Lasker; Ferdous Khan; Tahmina Yasmin; Khondker Ayesha Akter; Nusrat Subhan; Md Ashraful Alam
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-08-11       Impact factor: 3.000

8.  Role of inflammation in the pathogenesis of diabetic retinopathy.

Authors:  Ahmed M Abu El-Asrar
Journal:  Middle East Afr J Ophthalmol       Date:  2012-01

9.  Poorly controlled type 2 diabetes is accompanied by significant morphological and ultrastructural changes in both erythrocytes and in thrombin-generated fibrin: implications for diagnostics.

Authors:  Etheresia Pretorius; Janette Bester; Natasha Vermeulen; Sajee Alummoottil; Prashilla Soma; Antoinette V Buys; Douglas B Kell
Journal:  Cardiovasc Diabetol       Date:  2015-03-08       Impact factor: 9.951

10.  The stabilizing effect of an oligomeric proanthocyanidin on red blood cell membrane structure of poorly controlled Type II diabetes.

Authors:  J Visser; P J van Staden; P Soma; A V Buys; E Pretorius
Journal:  Nutr Diabetes       Date:  2017-05-15       Impact factor: 5.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.